Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 7;15(1):24302.
doi: 10.1038/s41598-025-08252-3.

Predictive factors at initial visit for sunset glow fundus in Vogt-Koyanagi-Harada disease

Affiliations

Predictive factors at initial visit for sunset glow fundus in Vogt-Koyanagi-Harada disease

Tetsuya Muto et al. Sci Rep. .

Abstract

This study aimed to identify factors present at the initial visit for the development of sunset glow fundus (SGF) in Vogt-Koyanagi-Harada (VKH) disease. A total of 139 eyes from 70 naïve patients with acute VKH disease who underwent pulse steroid therapy were categorized into "SGF" and "non-SGF" groups based on fundus appearance at 12 months post-therapy. Multivariable analysis revealed that patients with meningismus (p = 0.004), incomplete type (p = 0.035), and probable type (p = 0.002) in older revised diagnostic criteria; ex-smoker (p = 0.016), and smoker (p = 0.010) status; high logarithmic best-corrected visual acuity (BCVA) (p < 0.001); high spherical equivalent (SE) (p = 0.005); shallow peripheral anterior chamber depth (ACD) (p < 0.001); narrow anterior chamber angle (ACA) (p = 0.015); increased pupil diameter (p < 0.001); and thicker cornea (p = 0.019) were associated with SGF. The optimal cut-off values for predicting SGF were identified as follows: logarithmic BCVA greater than 0.261, SE exceeding - 2.813 D, peripheral ACD less than 2.138 mm, ACA less than 40.55 °, pupil diameter exceeding 3.040 mm, and corneal thickness exceeding 579.500 μm. Patients with VKH disease who exhibit above risk factors require early and careful management.

Keywords: Corneal thickness; Pupil diameter; Sunset glow fundus; Visual acuity; Vogt–Koyanagi–Harada disease.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
a Representative Pentacam images at the initial visit and color photos at 12 months for the SGF group after therapy. b Representative images for the non-SGF group. Increased pupil diameter, shallow peripheral ACD, and thick cornea were observed in the SGF group. ACD, anterior chamber depth; SGF, sunset glow fundus.
Fig. 2
Fig. 2
a Comparison of pupil diameter between SGF and non-SGF groups at the initial visit in both eyes. The cut-off value for BCVA was 0.261. b Comparison of SE between the groups. The cut-off value was −2.813 D. c Comparison of peripheral ACD between the groups. The cut-off value was 2.138 mm. d Comparison of peripheral ACA between the groups. The cut-off value was 40.550 °. e Comparison of pupil diameter between the groups. The cut-off value was 3.040 mm. f Comparison of corneal thickness between the groups. The cut-off value was 579.500 μm. ACA, anterior chamber angle; ACD, anterior chamber depth; BCVA, best-corrected visual acuity; SE, spherical equivalent; SGF, sunset glow fundus.
Fig. 3
Fig. 3
a Comparison of pupil diameter between SGF and non-SGF groups at the initial visit in the right eyes. The cut-off value for BCVA was 0.188. b Comparison of peripheral ACD between the groups. The cut-off value was 2.051 mm. c Comparison of pupil diameter between the groups. The cut-off value was 3.095 mm. ACD, anterior chamber depth; BCVA, best-corrected visual acuity; SGF, sunset glow fundus.

Similar articles

References

    1. Tayal, A., Daigavane, S. & Gupta, N. Vogt–Koyanagi–Harada disease: A narrative review. Cureus16, e58867 (2024). - PMC - PubMed
    1. Nakayama, M., Keino, H., Watanabe, T. & Okada, A. A. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt–Koyanagi–Harada disease treated with pulse intravenous corticosteroids. Br. J. Ophthalmol.103, 274–278 (2019). - PubMed
    1. Hirota, Y. et al. Association of retinal pigment epithelium reflectivity on optical coherence tomography with recurrence of Vogt–Koyanagi–Harada disease: A retrospective observational study. Clin. Ophthalmol.17, 2071–2079 (2023). - PMC - PubMed
    1. Abu El-Asrar, A. M. et al. Chronic recurrent Vogt–Koyanagi–Harada disease and development of ‘sunset glow fundus’ predict worse retinal sensitivity. Ocul Immunol. Inflamm.25, 475–485 (2017). - PubMed
    1. Hirooka, K. et al. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt–Koyanagi–Harada disease treated with systemic corticosteroids. PLoS One. 12, e0172612 (2017). - PMC - PubMed

LinkOut - more resources